MCID: HYP090
MIFTS: 48

Hyperalphalipoproteinemia malady

Categories: Genetic diseases, Metabolic diseases, Endocrine diseases, Rare diseases

Aliases & Classifications for Hyperalphalipoproteinemia

About this section
Sources:
49OMIM, 11diseasecard, 47Novoseek, 51Orphanet, 67UniProtKB/Swiss-Prot, 24GTR, 65UMLS, 28ICD10 via Orphanet, 34MedGen, 36MeSH, 61The Human Phenotype Ontology
See all MalaCards sources

Aliases & Descriptions for Hyperalphalipoproteinemia:

Name: Hyperalphalipoproteinemia 49 11 47 24
Cholesteryl Ester Transfer Protein Deficiency 67 65
Familial Hyperalphalipoproteinemia 51 65
Hyperalphalipoproteinemia 1 67 65
 
Cholesterol-Ester Transfer Protein Deficiency 51
Cept Deficiency 51
Cetp Deficiency 67
Halp1 67

Characteristics:

HPO:

61
hyperalphalipoproteinemia:
Inheritance: autosomal dominant inheritance


Classifications:



External Ids:

OMIM49 143470
Orphanet51 79506
ICD10 via Orphanet28 E78.4
MeSH36 D006951
UMLS65 C0342883, C3149462, C3875011

Summaries for Hyperalphalipoproteinemia

About this section
UniProtKB/Swiss-Prot:67 Hyperalphalipoproteinemia 1: A condition characterized by high levels of high density lipoprotein (HDL) and increased HDL cholesterol levels.

MalaCards based summary: Hyperalphalipoproteinemia, also known as cholesteryl ester transfer protein deficiency, is related to apolipoprotein c-iii deficiency and cetp-related hyperalphalipoproteinemia, and has symptoms including hyperalphalipoproteinemia An important gene associated with Hyperalphalipoproteinemia is CETP (Cholesteryl Ester Transfer Protein), and among its related pathways are triacylglycerol degradation and Cholesterol and Sphingolipids transport / Transport from Golgi and ER to the apical membrane (normal and CF). Affiliated tissues include lung, brain and breast, and related mouse phenotypes are pigmentation and endocrine/exocrine gland.

Description from OMIM:49 143470

Related Diseases for Hyperalphalipoproteinemia

About this section

Diseases in the Hyperalphalipoproteinemia family:

Cetp-Related Hyperalphalipoproteinemia

Diseases related to Hyperalphalipoproteinemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 111)
idRelated DiseaseScoreTop Affiliating Genes
1apolipoprotein c-iii deficiency30.0ABCA1, APOA1, APOA2, APOB, APOC3, CETP
2cetp-related hyperalphalipoproteinemia12.3
3spondylometaphyseal dysplasia, megarbane-dagher-melike type10.4LIPC, LPL
4hemochromatosis10.2
5amelogenesis imperfecta, type iia310.2APOA1, LIPC, LPL
6arsacs10.2APOE, LPL
7hereditary antithrombin deficiency10.2APOA1, APOA2
8amyloidosis beta2m10.2APOA1, LCAT
9hepatocellular carcinoma10.2
10schizophrenia10.2
11retinal degeneration, late-onset, autosomal dominant10.2APOE, LPL
12pigmentary cirrhosis10.2APOE, PLTP
13alzheimer disease-210.1APOE, LCAT
14distal myopathy with posterior leg and anterior hand involvement10.1APOE, LPL
15spinocerebellar ataxia 410.1APOA1, APOA2, LCAT
16pheochromocytoma10.1
17lung cancer10.1
18prostate cancer10.1
19coproporphyria10.1
20wolfram syndrome10.1
21aniridia10.1
22prader-willi syndrome10.1
23brain injury10.1
24hematopoietic stem cell transplantation10.1
25hepatitis10.1
26hepatitis b10.1
27leukemia10.1
28megakaryocytic leukemia10.1
29traumatic brain injury10.1
30usher syndrome10.1
31pyometritis10.1
32dirofilariasis10.1
33sarcoma10.1
34spinal meningioma10.1
35astigmatism10.1
36goiter10.1
37tolosa-hunt syndrome10.1
38endemic goiter10.1
39scleroperikeratitis10.1
40dumping syndrome10.1
41prostatitis10.1
42chromoblastomycosis10.1
43tularemia10.1
44angiodysplasia10.1
45agammaglobulinemia10.1
46epidermolysis bullosa10.1
47pulmonary tuberculosis10.1
48cerebritis10.1
49pseudomyxoma peritonei10.1
50congenital diaphragmatic hernia10.1

Graphical network of the top 20 diseases related to Hyperalphalipoproteinemia:



Diseases related to hyperalphalipoproteinemia

Symptoms for Hyperalphalipoproteinemia

About this section

Symptoms by clinical synopsis from OMIM:

143470

Clinical features from OMIM:

143470

HPO human phenotypes related to Hyperalphalipoproteinemia:

id Description Frequency HPO Source Accession
1 hyperalphalipoproteinemia HP:0012184

Drugs & Therapeutics for Hyperalphalipoproteinemia

About this section

Drugs for Hyperalphalipoproteinemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Adenosineapproved, investigational36358-61-760961
Synonyms:
(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose
1odi
2fqy
2gl0
30143-02-3
4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside
46946-45-6
46969-16-8
58-61-7
6-Amino-9-.beta.-ribofuranosyl-9H-purine
6-Amino-9-beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-delta-ribofuranosyl-9H-purine
9-(beta-D-Arabinofuranosyl)adenine
9-beta-D-Arabinofuranosyladenine
9-beta-D-Ribofuranosidoadenine
9-beta-D-Ribofuranosyl-9H-purin-6-amine
9-beta-D-Ribofuranosyladenine
9-beta-delta-Arabinofuranosyladenine
9-beta-delta-Ribofuranosidoadenine
9-beta-delta-Ribofuranosyl-9H-purin-6-amine
9-beta-delta-Ribofuranosyladenine
9beta-D-Ribofuranosyladenine
9beta-D-ribofuranosyl-9H-Purin-6-amine
9beta-delta-Ribofuranosyladenine
9beta-delta-ribofuranosyl-9H-Purin-6-amine
A0152
A4036_SIGMA
A9251_SIGMA
AC1L1U8O
AC1Q1ID3
AC1Q52XU
ADN
AI3-52413
Ade-Rib
Ade-rib
Adenin riboside
Adenine 9-beta-D-arabinofuranoside
Adenine deoxyribonucleoside
Adenine nucleoside
Adenine riboside
Adenine-9-beta-D-ribofuranoside
Adenine-9beta-D-Ribofuranoside
Adenine-9beta-delta-Ribofuranoside
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosina
Adenosine
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine, homopolymer
Adenosinum
Adensoine
Adenyldeoxyriboside
Ado
Adénosine
BB_NC-0565
BSPBio_001796
Bio1_000437
 
Bio1_000926
Bio1_001415
Boniton
C00212
CCRIS 2557
CHEBI:16335
CHEMBL477
CID60961
Caswell No. 010B
D000241
D00045
DB00640
Deoxyadenosine
Desoxyadenosine
EA6C60C2-6AFB-4264-A2F0-541373DB950E
EINECS 200-389-9
FT-0082881
HMS1920A13
HMS2091G13
KBio3_001296
LS-15085
MEDR-640
MLS000069638
MLS002153227
MolPort-001-838-229
Myocol
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NSC 627048
NSC 7652
NSC627048
NSC7652
Nucleocardyl
Pallacor
Polyadenosine
Polyriboadenosine
S1647_Selleck
SDCCGMLS-0003108.P003
SMR000058216
SPBio_001194
SPECTRUM1500107
SR 96225
SR-96225
SUN-Y4001
Sandesin
Spectrum2_001257
Spectrum3_000288
TL8003749
UNII-K72T3FS567
USAF CB-10
V0098
Vidarabine
ZINC02169830
adenine-D-ribose
adenosine
b-D-Adenosine
beta-Adenosine
beta-D-Adenosine
beta-D-Ribofuranoside, adenine-9
beta-delta-Adenosine
bmse000061
nchembio.143-comp9
nchembio.186-comp109
nchembio.2007.56-comp13
nchembio.64-comp4
nchembio706-5
2Pharmaceutical Solutions7004

Interventional clinical trials:

idNameStatusNCT IDPhase
1Relationship Between CETP Deficiency and Atherosclerosis in Patients With HyperalphalipoproteinemiaRecruitingNCT01916512
2Genes Involved in Lipid DisordersRecruitingNCT02311335
3Causes and Natural History of DyslipidemiasRecruitingNCT00353782
4Mendelian Reverse Cholesterol Transport StudyRecruitingNCT01782027

Search NIH Clinical Center for Hyperalphalipoproteinemia

Genetic Tests for Hyperalphalipoproteinemia

About this section

Anatomical Context for Hyperalphalipoproteinemia

About this section

MalaCards organs/tissues related to Hyperalphalipoproteinemia:

33
Lung, Brain, Breast, Thymus, Colon, Testes, T cells

Animal Models for Hyperalphalipoproteinemia or affiliated genes

About this section

MGI Mouse Phenotypes related to Hyperalphalipoproteinemia:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00011868.2ABCA1, APOB, APOE, LDLR
2MP:00053797.6ABCA1, APOA1, APOE, LCAT, LDLR, LIPC
3MP:00053917.6ABCA1, APOB, APOE, LCAT, LDLR, PLTP
4MP:00053706.9ABCA1, APOA1, APOB, APOE, LCAT, LDLR
5MP:00053856.2ABCA1, APOA1, APOB, APOE, LCAT, LDLR
6MP:00053764.9ABCA1, APOA1, APOA2, APOB, APOE, LCAT

Publications for Hyperalphalipoproteinemia

About this section

Articles related to Hyperalphalipoproteinemia:

(show top 50)    (show all 62)
idTitleAuthorsYear
1
Effect of Donepezil on Wernicke Aphasia After Bilateral Middle Cerebral Artery Infarction: Subtraction Analysis of Brain F-18 Fluorodeoxyglucose Positron Emission Tomographic Images. (26166237)
2015
2
Reply to Letters From Madias and Y-Hassan-With Regard to "Spontaneous Coronary Artery Dissection Misdiagnosed as Takotsubo Cardiomyopathy: A Case Series". (26440510)
2015
3
Eradication of H. pylori infection in patients allergic to penicillin using triple therapy with a PPI, metronidazole and sitafloxacin. (24633026)
2014
4
Relevance of novel inflammatory markers in stroke-induced immunosuppression. (24597828)
2014
5
Retinitis due to Opportunistic Infections in Iranian HIV Infected Patients. (24338145)
2013
6
Novel technique of implantation for reversed modified right lobe graft from a donor with situs inversus totalis: new challenge in adult living donor liver transplantation. (23879322)
2013
7
Osteochondritis dissecans knee histology studies have variable findings and theories of etiology. (23054514)
2013
8
The state of the art in the technical performance of lung-sparing operations for malignant pleural mesothelioma. (24216529)
2013
9
Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia. (22958163)
2012
10
ABCG2 null alleles define the Jr(a-) blood group phenotype. (22246507)
2012
11
Borderline personality disorder features and history of childhood maltreatment in mothers involved with child protective services. (22593244)
2012
12
c-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation rather than oncogenesis. (22126447)
2012
13
Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis. (20116187)
2010
14
Are ghrelin and leptin involved in food intake and body mass index in maintenance hemodialysis? (19913442)
2010
15
Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. (19344998)
2009
16
Testicular feminization with persistent wolffian duct and mA1llerian remnants: similar to Mayer-Rokitansky-Kuster-Hauser syndrome. (19423097)
2009
17
Health-related quality of life in elderly patients with familial hypercholesterolemia. (18400127)
2008
18
Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. (17984093)
2008
19
2-o-phosphorylation of xylose and 6-o-sulfation of galactose in the protein linkage region of glycosaminoglycans influence the glucuronyltransferase-I activity involved in the linkage region synthesis. (18400750)
2008
20
Is there a major role for adenosine A2A receptors in anxiety? (18508500)
2008
21
Correlation of CD40 gene polymorphisms with acute coronary syndrome, hypertension and diabetes]. (17553307)
2007
22
Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation]. (17430668)
2007
23
Expressions of cyclin D1 and p16 in hypopharyngeal squamous cell carcinoma and their clinical significance]. (17634024)
2007
24
Hay-wells syndrome of ectodermal dysplasia. (16444073)
2006
25
Clinical features and epileptogenesis of dysembryoplastic neuroepithelial tumor. (16944177)
2006
26
A comparison of cyclic neutropenia in childhood and severe congenital neutropenia. (16079089)
2005
27
Increased alpha 7 nicotinic acetylcholine receptor protein levels in Alzheimer's disease patients. (15591800)
2005
28
Regulation of sphingosine-1-phosphate lyase gene expression by members of the GATA family of transcription factors. (15734735)
2005
29
A proatherogenic role for C-reactive protein in vivo. (16148535)
2005
30
Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, FcgammaRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcgammaRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility. (15535834)
2004
31
The surgical management of congenital hyperinsulinemic hypoglycemia in infancy. (15017535)
2004
32
Sporotrichosis with widespread cutaneous lesions: report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil. (12956676)
2003
33
Difference in gene expression profile in breast epithelial cells from women with different reproductive history. (12963971)
2003
34
Effects of bu yang huan wu decoction on astrocytes after cerebral ischemia and reperfusion]. (12776558)
2002
35
A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. (11923911)
2002
36
Nuclear and cytoplasmic tau proteins from human nonneuronal cells share common structural and functional features with brain tau. (10842324)
2000
37
A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin. (10411572)
1999
38
Large-scale production and purification of the human green cone pigment: characterization of late photo-intermediates. (9494086)
1998
39
Cat scratch disease. (9551385)
1998
40
CT-verified intracranial calcifications and contrast enhancement in acute disseminated encephalomyelitis: a case report. (9716628)
1998
41
Microfocal radiography in the diagnosis of childhood renal osteodystrophy. (9821707)
1998
42
The expression of VLA integrins in the human thymus. (8717325)
1996
43
Molecular markers help characterize neuroendocrine lung tumors. (8784011)
1996
44
Effects of integrin clustering on human lung mast cells and basophils. (8534491)
1996
45
Cell- and region-specific expression of biliary glycoprotein and its messenger RNA in normal human colonic mucosa. (7606710)
1995
46
Human lymphocyte cDNA ordered library analyzed by 2D gel electrophoresis. 3. Analysis of individual clones. (8573604)
1995
47
Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group. (7758882)
1995
48
Restaurant-associated outbreak of giardiasis. (1500757)
1992
49
Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. (1705008)
1991
50
Canine otitis externa caused by the fungus Sporothrix schenkii. (638939)
1978

Variations for Hyperalphalipoproteinemia

About this section

UniProtKB/Swiss-Prot genetic disease variations for Hyperalphalipoproteinemia:

67
id Symbol AA change Variation ID SNP ID
1CETPp.Asp459GlyVAR_004172rs2303790
2CETPp.Leu168ProVAR_033099
3CETPp.Arg299CysVAR_033100

Clinvar genetic disease variations for Hyperalphalipoproteinemia:

5
id Gene Variation Type Significance SNP ID Assembly Location
1CETPCETP, IVS14DS, G-A, +1single nucleotide variantPathogenic
2CETPNM_000078.2(CETP): c.1376A> G (p.Asp459Gly)single nucleotide variantPathogenicrs2303790GRCh37Chr 16, 57017292: 57017292
3CETPCETP, 1-BP INS, T, IVS14, +3insertionPathogenic

Expression for genes affiliated with Hyperalphalipoproteinemia

About this section
Search GEO for disease gene expression data for Hyperalphalipoproteinemia.

Pathways for genes affiliated with Hyperalphalipoproteinemia

About this section

Pathways related to Hyperalphalipoproteinemia according to GeneCards Suite gene sharing:

(show all 18)
idSuper pathwaysScoreTop Affiliating Genes
19.7LIPC, LIPG
29.6ABCA1, CETP
39.4ABCA1, LDLR
49.3APOA1, APOB, SCARB1
5
Show member pathways
9.3LDLR, LPL, SCARB1
6
Show member pathways
9.3LIPC, LIPG, LPL
79.2APOE, LDLR
89.2ABCA1, APOA1, APOA2
9
Show member pathways
8.9APOA1, APOA2, APOC3, LPL, PLTP
108.7ABCA1, APOA1, APOB, SCARB1
11
Show member pathways
8.5APOA1, APOB, APOE, SCARB1
12
Show member pathways
8.4ABCA1, APOA1, APOE, SCARB1
13
Show member pathways
8.3ABCA1, APOA1, APOB, LDLR, SCARB1
14
Show member pathways
7.3APOA1, APOA2, APOB, APOC3, APOE, LDLR
15
Show member pathways
7.3APOA1, APOA2, APOB, APOC3, APOE, LDLR
16
Show member pathways
5.3ABCA1, APOA1, APOA2, APOB, APOC3, APOE
17
Show member pathways
4.7ABCA1, APOA1, APOA2, APOB, APOC3, APOE
18
Show member pathways
4.7ABCA1, APOA1, APOA2, APOB, APOC3, APOE

GO Terms for genes affiliated with Hyperalphalipoproteinemia

About this section

Cellular components related to Hyperalphalipoproteinemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1intermediate-density lipoprotein particleGO:003436310.2APOB, APOC3
2clathrin-coated endocytic vesicle membraneGO:003066910.0APOB, LDLR
3Golgi apparatusGO:00057949.2APOB, LDLR
4early endosomeGO:00057698.2APOA1, APOA2, APOB, APOC3, APOE

Biological processes related to Hyperalphalipoproteinemia according to GeneCards Suite gene sharing:

(show all 45)
idNameGO IDScoreTop Affiliating Genes
1blood vessel endothelial cell migrationGO:004353410.5APOA1, SCARB1
2phosphatidylcholine metabolic processGO:004647010.5CETP, LCAT
3peptidyl-methionine modificationGO:001820610.5APOA1, APOA2
4chylomicron remodelingGO:003437110.4LIPC, LPL
5cholesterol importGO:007050810.4APOA1, LDLR
6very-low-density lipoprotein particle assemblyGO:003437910.3APOB, APOC3
7organ regenerationGO:003110010.3APOA1, APOA2
8protein oxidationGO:001815810.3APOA1, APOA2
9phospholipid catabolic processGO:000939510.2APOA2, LIPG
10positive regulation of macrophage derived foam cell differentiationGO:001074410.1APOB, LPL
11lipid catabolic processGO:001604210.1APOB, LPL
12regulation of Cdc42 protein signal transductionGO:003248910.1APOC3, APOE
13viral entry into host cellGO:004671810.1LDLR, SCARB1
14chylomicron remnant clearanceGO:003438210.0APOE, LIPC
15neuron projection regenerationGO:003110210.0APOA1, APOE
16very-low-density lipoprotein particle remodelingGO:003437210.0APOE, CETP
17cholesterol catabolic processGO:000670710.0APOE, SCARB1
18phosphatidylcholine biosynthetic processGO:000665610.0APOA1, APOA2, LCAT
19triglyceride homeostasisGO:00703289.7APOA1, CETP, LPL, SCARB1
20high-density lipoprotein particle assemblyGO:00343809.7ABCA1, APOE
21response to nutrientGO:00075849.7ABCA1, APOA1, APOC3
22lipoprotein metabolic processGO:00421579.6ABCA1, APOC3, LPL
23positive regulation of cholesterol esterificationGO:00108739.6APOA1, APOA2, APOE
24lipoprotein biosynthetic processGO:00421589.6APOA1, APOA2, APOE
25low-density lipoprotein particle clearanceGO:00343839.6APOB, LIPC, SCARB1
26low-density lipoprotein particle remodelingGO:00343749.4APOA2, APOB, APOE
27phospholipid homeostasisGO:00550919.4ABCA1, APOA1, CETP, LIPG
28phospholipid transportGO:00159149.4ABCA1, CETP, LDLR, SCARB1
29receptor-mediated endocytosisGO:00068989.4APOA1, APOE, CETP
30phospholipid effluxGO:00337009.4APOA1, APOA2, APOC3, APOE
31lipoprotein catabolic processGO:00421599.3APOB, APOE, LDLR
32response to drugGO:00424939.3APOA1, APOA2, APOC3, LIPC
33cholesterol metabolic processGO:00082039.2APOB, APOE, LDLR
34triglyceride catabolic processGO:00194339.1APOB, APOC3, APOE, LPL
35cholesterol transportGO:00303019.0ABCA1, APOA2, CETP, LCAT, LIPC
36triglyceride metabolic processGO:00066419.0APOA2, APOC3, APOE, CETP, LIPC
37high-density lipoprotein particle remodelingGO:00343758.9APOA1, APOA2, APOC3, CETP, LCAT, LIPC
38retinoid metabolic processGO:00015238.6APOA1, APOB, APOC3, APOE, LPL
39lipid metabolic processGO:00066298.4APOB, APOE, LCAT, LIPC, LPL
40lipid transportGO:00068698.1APOA2, APOB, APOC3, APOE, CETP, PLTP
41phototransduction, visible lightGO:00076038.1APOA1, APOA2, APOB, APOC3, APOE, LPL
42cholesterol effluxGO:00333448.0ABCA1, APOA1, APOA2, APOB, APOE, SCARB1
43small molecule metabolic processGO:00442817.9ABCA1, APOA1, APOA2, APOC3, LCAT, LIPC
44reverse cholesterol transportGO:00436917.6ABCA1, APOA1, APOA2, APOC3, APOE, LCAT
45cholesterol homeostasisGO:00426327.0ABCA1, APOA2, APOC3, APOE, LDLR, LIPC

Molecular functions related to Hyperalphalipoproteinemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1high-density lipoprotein particle bindingGO:000803510.1APOA1, APOA2
2lipid bindingGO:000828910.0CETP, LIPC
3high-density lipoprotein particle receptor bindingGO:00706539.8APOA1, APOA2, APOC3
4heparin bindingGO:00082019.2LIPC, LIPG, LPL

Sources for Hyperalphalipoproteinemia

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet